APOSEC - Model APO-2 -Topical formulation for the treatment of diabetic foot ulcers and other chronic wounds

Aposcience AG will initiate a program to demonstrate safety and efficacy in this important indication with very large unmet medical need. The program consists of a phase I study in healthy volunteers, followed by a phase IIa study in a selected patient population. This program is designed to translate the extremely promising data from animal models into clinical practice.